We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Cyberonics' VNS Device for Treatment of Adult Depression
FDA Approves Cyberonics' VNS Device for Treatment of Adult Depression
July 22, 2005
Houston-based devicemaker Cyberonics won a lengthy battle last week when a premarket approval application supplement for its vagus nerve stimulation (VNS) therapy system was approved by the FDA “for the adjunctive long-term treatment of chronic or recurrent depression in adults.” The device has been approved for treatment-resistant depression (TRD) in Europe and Canada since 2001.